Verve Therapeutics
VERV
#6547
Rank
โ‚ฌ0.49 B
Marketcap
5,89ย โ‚ฌ
Share price
-0.79%
Change (1 day)
-59.81%
Change (1 year)

P/S ratio for Verve Therapeutics (VERV)

P/S ratio as of November 2024 (TTM): 25.9

According to Verve Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.9783. At the end of 2024 the company had a P/S ratio of 19.8.

P/S ratio history for Verve Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202419.8-79.19%
202395.3-84.47%
2022614
2021N/A